论文部分内容阅读
The features and advantages of Chinese medicine(CM) in cancer comprehensive treatment have been in the spotlight of experts both at home and abroad.However,how to evaluate the effect of CM more objectively,scientifically and systematically is still the key problem of clinical trial,and also a limitation to the development and internationalization of CM oncology.The change of tumor response evaluation system in conventional medicine is gradually consistent with the features of CM clinical effect,such as they both focus on a combination of soft endpoints (i.e.quality of life,clinical benefit,etc.) and hard endpoints(i.e.tumor remission rate,time to progress,etc.).Although experts have proposed protocols of CM tumor response evaluation criteria and come to an agreement in general,divergences still exist in the importance,quantification and CM feature of the potential endpoints. Thus,establishing a CM characteristic and wildly accepted tumor response evaluation system is the key to promote internationalization of CM oncology,and also provides a more convenient and scientific platform for CM international cooperation and communication.
The features and advantages of Chinese medicine (CM) in cancer comprehensive treatment have been in the spotlight of experts both at home and abroad. However, how to evaluate the effect of CM more objectively, scientifically and systematically is still the key problem of clinical trial , and also a limitation to the development and internationalization of CM oncology.The change of tumor response evaluation system in conventional medicine is gradually consistent with the features of CM clinical effect, such as as both of which focus on a combination of soft endpoints (iequality of life, clinical benefit, etc.) and hard endpoints (ietumor remission rate, time to progress, etc.). Though experts have proposed protocols of CM tumor response evaluation criteria and come to an agreement in general, divergences still exist in the importance , quantification and CM feature of the potential endpoints. Thus, establishing a CM characteristic and wildly accepted tumor response evaluation system is the key to promote internationalization of CM oncology, and also provide a more convenient and scientific platform for CM international cooperation and communication.